Mylan disclosed that its chairman, Robert J. Coury, received nearly $100 million last year, among the largest 2016 pay packages, even as the drugmaker was buffeted by a furor over hefty price increases on its lifesaving EpiPen.
from WSJ.com: US Business http://ift.tt/2p45ew0
via IFTTT
No comments:
Post a Comment